Commonwealth Equity Services’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $171K | Buy |
|
|||||
|
2025
Q2 | $56K | Buy |
|
|||||
|
2025
Q1 | $27K | Hold |
|
|||||
|
2024
Q4 | $30K | Buy |
|
|||||
|
2024
Q3 | $44K | Buy |
|
|||||
|
2024
Q2 | $48K | Hold |
|
|||||
|
2024
Q1 | $71K | Hold |
|
|||||
|
2023
Q4 | $52K | Sell |
|
|||||
|
2023
Q3 | $64K | Buy |
|
|||||
|
2023
Q2 | $73K | Buy |
|
|||||
|
2023
Q1 | $72 | Sell |
|
|||||
|
2022
Q4 | $57K | Buy |
|
|||||
|
2022
Q3 | $48K | Sell |
|
|||||
|
2022
Q2 | $71K | Buy |
|
|||||
|
2022
Q1 | $70K | Buy |
|
|||||
|
2021
Q4 | $94K | Sell |
|
|||||
|
2021
Q3 | $110K | Sell |
|
|||||
|
2021
Q2 | $154K | Buy |
|
|||||
|
2021
Q1 | $113K | Sell |
|
|||||
|
2020
Q4 | $158K | Sell |
|
|||||
|
2020
Q3 | $85K | Buy |
|
|||||
|
2020
Q2 | $74K | Buy |
|
|||||
|
2020
Q1 | $61K | Buy |
|
|||||
|
2019
Q4 | $59K | Sell |
|
|||||
|
2019
Q3 | $112K | Sell |
|
|||||
|
2019
Q2 | $130K | Buy |
|
|||||
|
2019
Q1 | $151K | Buy |
|
|||||
|
2018
Q4 | $87K | Sell |
|
|||||
|
2018
Q3 | $206K | Buy |
|
|||||
|
2018
Q2 | $169K | Buy |
|
|||||
|
2018
Q1 | $217K | Buy |
|
|||||
|
2017
Q4 | $130K | Buy |
|
|||||
|
2017
Q3 | $171K | Hold |
|
|||||
|
2017
Q2 | $189K | Buy |
|
|||||
|
2017
Q1 | $78K | Buy |
|
|||||
|
2016
Q4 | $72K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $44K | Sell |
|
|||||
|
2013
Q2 | $54K | Buy |
|